Trial Outcomes & Findings for Mommy-Baby Treatment for Perinatal Depression (NCT NCT01744041)

NCT ID: NCT01744041

Last Updated: 2022-01-11

Results Overview

Edinburgh Postnatal Depression Scale, a 10-item scale of depression severity, scores range from 0 to 30 with higher scores indicating worse outcome.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

42 participants

Primary outcome timeframe

Change from baseline at End of pregnancy (between 37-39 weeks gestation); change from baseline at 3 months postpartum; change from baseline at 6 months postpartum; change from baseline at 9 months postpartum; change from baseline at 12 months postpartum

Results posted on

2022-01-11

Participant Flow

Participant milestones

Participant milestones
Measure
Dyadic Interpersonal Psychotherapy
Brief Interpersonal Psychotherapy during pregnancy followed by dyadic mother-infant psychotherapy for one year postpartum Dyadic Interpersonal Psychotherapy: This intervention consists of a brief psychotherapeutic intervention, Interpersonal Psychotherapy, during pregnancy. Interpersonal Psychotherapy focuses on improving social relationships and interpersonal communication to improve mood. The postpartum phase also utilizes developmentally appropriate strategies to improve the mother-infant relationship.
Enhanced Treatment as Usual
Personalized referral to community resources for depression treatment Enhanced Treatment as Usual: This intervention consists of personalized referrals to specialty mental health providers, spiritual counselors, or other needed social services. It includes some non-specific supportive techniques delivered primarily via telephone.
Overall Study
STARTED
21
21
Overall Study
COMPLETED
15
13
Overall Study
NOT COMPLETED
6
8

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Mommy-Baby Treatment for Perinatal Depression

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Dyadic Interpersonal Psychotherapy
n=21 Participants
Brief Interpersonal Psychotherapy during pregnancy followed by dyadic mother-infant psychotherapy for one year postpartum Dyadic Interpersonal Psychotherapy: This intervention consists of a brief psychotherapeutic intervention, Interpersonal Psychotherapy, during pregnancy. Interpersonal Psychotherapy focuses on improving social relationships and interpersonal communication to improve mood. The postpartum phase also utilizes developmentally appropriate strategies to improve the mother-infant relationship.
Enhanced Treatment as Usual
n=21 Participants
Personalized referral to community resources for depression treatment Enhanced Treatment as Usual: This intervention consists of personalized referrals to specialty mental health providers, spiritual counselors, or other needed social services. It includes some non-specific supportive techniques delivered primarily via telephone.
Total
n=42 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
21 Participants
n=5 Participants
21 Participants
n=7 Participants
42 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Continuous
26.9 years
STANDARD_DEVIATION 5.81 • n=5 Participants
26.38 years
STANDARD_DEVIATION 5.9 • n=7 Participants
26.64 years
STANDARD_DEVIATION 5.79 • n=5 Participants
Sex: Female, Male
Female
21 Participants
n=5 Participants
21 Participants
n=7 Participants
42 Participants
n=5 Participants
Sex: Female, Male
Male
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
21 Participants
n=5 Participants
20 Participants
n=7 Participants
41 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
17 Participants
n=5 Participants
16 Participants
n=7 Participants
33 Participants
n=5 Participants
Race (NIH/OMB)
White
4 Participants
n=5 Participants
3 Participants
n=7 Participants
7 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
Region of Enrollment
United States
21 participants
n=5 Participants
21 participants
n=7 Participants
42 participants
n=5 Participants
Edinburgh Depression Scale score
17.81 units on a scale
STANDARD_DEVIATION 3.71 • n=5 Participants
17.90 units on a scale
STANDARD_DEVIATION 4.60 • n=7 Participants
17.86 units on a scale
STANDARD_DEVIATION 4.13 • n=5 Participants

PRIMARY outcome

Timeframe: Change from baseline at End of pregnancy (between 37-39 weeks gestation); change from baseline at 3 months postpartum; change from baseline at 6 months postpartum; change from baseline at 9 months postpartum; change from baseline at 12 months postpartum

Population: Data shown are for the participants who completed study questionnaires at that time-point. Due to participant drop-out, this number may be less than the overall number of participants analyzed.

Edinburgh Postnatal Depression Scale, a 10-item scale of depression severity, scores range from 0 to 30 with higher scores indicating worse outcome.

Outcome measures

Outcome measures
Measure
Dyadic Interpersonal Psychotherapy
n=21 Participants
Brief Interpersonal Psychotherapy during pregnancy followed by dyadic mother-infant psychotherapy for one year postpartum Dyadic Interpersonal Psychotherapy: This intervention consists of a brief psychotherapeutic intervention, Interpersonal Psychotherapy, during pregnancy. Interpersonal Psychotherapy focuses on improving social relationships and interpersonal communication to improve mood. The postpartum phase also utilizes developmentally appropriate strategies to improve the mother-infant relationship.
Enhanced Treatment as Usual
n=21 Participants
Personalized referral to community resources for depression treatment Enhanced Treatment as Usual: This intervention consists of personalized referrals to specialty mental health providers, spiritual counselors, or other needed social services. It includes some non-specific supportive techniques delivered primarily via telephone.
Change in Edinburgh Depression Scale From Baseline
Baseline Score
17.81 units on a scale
Standard Deviation 3.71
17.9 units on a scale
Standard Deviation 4.6
Change in Edinburgh Depression Scale From Baseline
37-39 week gestation score
12.04 units on a scale
Standard Deviation 1.22
11.41 units on a scale
Standard Deviation 1.72
Change in Edinburgh Depression Scale From Baseline
3-month postpartum score
11.0 units on a scale
Standard Deviation 6.1
10.3 units on a scale
Standard Deviation 6.8
Change in Edinburgh Depression Scale From Baseline
6-month postpartum score
9.5 units on a scale
Standard Deviation 2.9
9.4 units on a scale
Standard Deviation 5.8
Change in Edinburgh Depression Scale From Baseline
9-month postpartum score
10.6 units on a scale
Standard Deviation 5.9
9.4 units on a scale
Standard Deviation 4.7
Change in Edinburgh Depression Scale From Baseline
12-month postpartum score
10.8 units on a scale
Standard Deviation 4.0
8.8 units on a scale
Standard Deviation 4.9

Adverse Events

Dyadic Interpersonal Psychotherapy

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Enhanced Treatment as Usual

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Shannon Lenze

Washington University - School of Medicine

Phone: 3143622752

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place